Clinical Focus

Previous Articles     Next Articles

Prediction of no reflow phenomenon in patients with acute myocardial infarction  undergoing coronary intervention by CHA2DS2VASc score

  

  1. Department of Cardiology, Fuxin  Center Hospital, Fuxin 123000, China
  • Online:2020-09-20 Published:2020-07-09
  • Contact: Corresponding author:Sun Wei, Email: shuyanchencn@hotmail.com

Abstract: Objective   To verify the clinical predictive value of CHA2DS2VASc score in the absence of reflow in STsegment elevation myocardial infarction (STEMI) patients after direct  percutaneous coronary intervention (PCI). Methods   300 STEMI patients admitted to our hospital for primary PCI were divided into two groups: 27 patients without reflow as the first group, and the remaining 273 patients as the control group. CHA2DS2VASc risk score was calculated for each patient.Results  There was statistically  significant difference in multivariate analysis between CHA2DS2VASc score and nonreflow correlation (P<0.05).The components of CHA2DS2VASc score showed  significant differences in the prediction ability of nonreflow(P<0.05). ConclusionIn  STEMI patients treated with primary PCI, higher CHA2DS2VASc score was associated with the risk of no reflow and inhospital mortality.

Key words: myocardial infarction, angioplasty, transluminal, , percutaneous coronary, electrocardiography